Isoenzymes of alkaline phosphatase - Useful parameters for identification of bone metastasis in prostatic carcinoma?

Onkologie

Volumn 23, Issue 1, 2000, Pages 42-46

  Paul, R ^a   Bottermann, R ^b   Breul, J ^b   Hartung, R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Alkaline phosphatase; Bone metastasis; Bone specific alkaline phosphatase; Prostatic neoplasm

Indexed keywords

ALKALINE PHOSPHATASE; ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER RISK; CANCER STAGING; DIAGNOSTIC APPROACH ROUTE; HUMAN; MALE; PROSTATE CARCINOMA; REACTION ANALYSIS; TISSUE SPECIFICITY;

EID: 0034018207     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027066     Document Type: Article

References (21)

1. Schaffer DL, Pendergrass HP: Comparison of enzyme, clinical, radiographic and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Nucl Med 1976;121:431-434.
2. Wolff JM, Ittel T, Borchers H, Brauers A, Jakse G: Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate. Urol Int 1998;61: 12-16.
3. Murphy GP, Trochak MJ, Cobb OE, Bowes VA, Kenny RJ, Barren RJ, Kenny GM, Ragde H, Holmes EH, Wolfer RL: Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. Prostate 1997;33: 141-146.
4. Wolff JM, Ittel TH, Boeckmann W, Habib FK, Jakse G: Metastatic workup of patients with prostate cancer employing skeletal alkaline phosphatase. Anticancer Res 1997;17:2995-2997.
5. Desoize B, Amico S, Larbre H, Coninx P, Jardillier J-C: Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma. Clin Biochem 1991; 24:443-446.
6. Merrick MV, Ding CC, Chisholm GD, Elton RA: Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol 1985;57:715-720.
7. Cowan RJ, Young KA: Evaluation of serum alkaline phosphatase determination in patients with positive bone scans. Cancer 1973;32:887-889.
8. Cooper EH, Whelan P, Purves D: Bone alkaline phosphatase and prostate specific antigen in the monitoring of prostate cancer. Prostate 1994;25: 236-242.
9. Wirtz DC, Wolff JM, Ittel TH, Jakse G, Niethard FU: Ist die skelettalkalische Phosphatase ein valider Stagingmarker zum Nachweis osteoblastischer Skelettmetastasen des Prostatakarzinoms? Z Orthop Grenzgeb 1998;136:255-259.
10. Imai K, Tomaru Y, Ohmuki T, Yamanaka H, Sakai H, Kanetake H, Minami Y, Nomata K, Saito Y: Significance of a new stratification of alkaline phosphatase and extent of disease in patients with prostate carcinoma with bone metastasis. Cancer 1992;69: 2983-2989.
11. Akimoto S, Furuya Y, Akakura K, Ito H: Comparison of markers of bone formation and resoption in prostate cancer patients to predict bone metastasis. Endocrin J 1998;45:97-104.
12. Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H: Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade. Prostate 1999;38:28-34.
13. Oesterling JE: Using PSA to eliminate the staging radionuclide bone scan. Urol Clin N Am 1993; 20:705-711.
14. Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H: Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: Comparison with prostatic acid phosphatase and alkaline phosphatase. Int J Urol 1997;4:572-575.
15. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC: Serum PSA after anatomic radical prostatectomy. Urol Clin N Am 1993;20:713-725.
16. Strohmaier WL, Keller T, Bichler KH: Follow-up in prostate cancer patients: Which parameters are necessary? Eur Urol 1999;35:21-25.
17. Stokkel MP, Zwinderman AH, Zwartendijk J, Pauwels EK, Van Eck-Smit BL: The value of pretreatment clinical and biochemical parameters in staging and prognostic stratification of patients with newly diagnosed prostate carcinoma. Int J Biol Markers 1998;13:70-76.
18. Desoize B, Veiler V, Pourny C, Comoe L, Jardillier JC: Isoenzymes of alkaline and acid phosphatases as bone metastasis marker in breast cancer patients. Anticancer Res 1989;9:1105.
19. Tavassoli M, Rizo M, Lung TY: Elevation of serum acid phosphatase in cancers with bone metastasis. Cancer 1980;45:2400-2403.
20. Eyre D: Editorial: New biomarkers of bone resorption. J Clin Endocrin Metab 1992;74:470A-470C
21. Akimoto S, Inomiya H, Furuya Y, Akakura K, Ito H: Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis. Eur Urol 1998;3: 142-147.